Literature DB >> 30084930

Recent advances in development of cell-free protein synthesis systems for fast and efficient production of recombinant proteins.

Kyung-Ho Lee1, Dong-Myung Kim1.   

Abstract

Cell-free protein synthesis has emerged in recent years as a powerful tool that can potentially transform the production of recombinant proteins. Cell-free protein synthesis harnesses the synthetic power of living cells while eliminating many of the constraints of traditional cell-based gene expression methods. Due to the lack of physical barriers separating the protein synthesis machinery from the surrounding environment, a cell-free protein synthesis reaction mixture can be directly programmed using diverse genetic material for the instant production of recombinant proteins without complicated cloning procedures. However, a number of issues must be addressed for this technology to be widely accepted as an alternative platform for protein production, including quality-control of translation machinery preparations, and high reagent cost. This review describes recent efforts to make cell-free protein synthesis more affordable and more easily accessible for generic applications.

Mesh:

Substances:

Year:  2018        PMID: 30084930     DOI: 10.1093/femsle/fny174

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  6 in total

1.  A Crude Extract Preparation and Optimization from a Genomically Engineered Escherichia coli for the Cell-Free Protein Synthesis System: Practical Laboratory Guideline.

Authors:  Jeehye Kim; Caroline E Copeland; Sahana R Padumane; Yong-Chan Kwon
Journal:  Methods Protoc       Date:  2019-08-09

Review 2.  Escherichia coli Extract-Based Cell-Free Expression System as an Alternative for Difficult-to-Obtain Protein Biosynthesis.

Authors:  Sviatlana Smolskaya; Yulia A Logashina; Yaroslav A Andreev
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

3.  Constructing Cell-Free Expression Systems for Low-Cost Access.

Authors:  Fernando Guzman-Chavez; Anibal Arce; Abhinav Adhikari; Sandra Vadhin; Jose Antonio Pedroza-Garcia; Chiara Gandini; Jim W Ajioka; Jenny Molloy; Sobeida Sanchez-Nieto; Jeffrey D Varner; Fernan Federici; Jim Haseloff
Journal:  ACS Synth Biol       Date:  2022-03-08       Impact factor: 5.249

Review 4.  Full-length recombinant antibodies from Escherichia coli: production, characterization, effector function (Fc) engineering, and clinical evaluation.

Authors:  Md Harunur Rashid
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

5.  I n situ synthesis and unidirectional insertion of membrane proteins in liposome-immobilized silica stationary phase for rapid preparation of microaffinity chromatography.

Authors:  Yanqiu Gu; Rong Wang; Panpan Chen; Shengnan Li; Xinyi Chai; Chun Chen; Yue Liu; Yan Cao; Diya Lv; Zhanying Hong; Zhenyu Zhu; Yifeng Chai; Yongfang Yuan; Xiaofei Chen
Journal:  Acta Pharm Sin B       Date:  2022-04-22       Impact factor: 14.903

Review 6.  Cell-Free Protein Synthesis: A Promising Option for Future Drug Development.

Authors:  Srujan Kumar Dondapati; Marlitt Stech; Anne Zemella; Stefan Kubick
Journal:  BioDrugs       Date:  2020-06       Impact factor: 5.807

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.